This analysis revealed that some MAGEs including MAGED subfamily are overexpressed, while most others including MAGEE1, MAGEE2, MAGEL2, MAGEH1, NDN, and TRO are downregulated in glioma. The gene discussed is MAGEH1; the disease is central nervous system cancer.